Beyond Air Price Target Cut to $8.00/Share From $10.00 by Truist Securities
Beyond Air Price Target Cut to $8.00/Share From $10.00 by Truist Securities
Dow JonesApr 30 13:16 ET
Beyond Air Is Maintained at Buy by Truist Securities
Beyond Air Is Maintained at Buy by Truist Securities
Dow JonesApr 30 13:16 ET
Beyond Air Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/30/2024 606.9% Truist Securities $10 → $8 Maintains Buy 11/14/2023 783.63% Truist Securities $14 → $10
BenzingaApr 30 13:05 ET
Truist Lowers Price Target on Beyond Air to $8 From $10, Keeps Buy Rating
Beyond Air (XAIR) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $7 to $19.
MT NewswiresApr 30 07:17 ET
Express News | Beyond Air Inc : Truist Securities Cuts Target Price to $8 From $10
ReutersApr 30 06:57 ET
Beyond Air Rises After Pricing Its $16M Direct Offering
Seeking AlphaMar 20 09:18 ET
Express News | Beyond Air Announces Pricing Of $16M Registered Direct Offering Of Common Stock and Warrants
Moomoo 24/7Mar 20 09:06 ET
Beyond Air Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
GARDEN CITY, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of
GlobeNewswireMar 20 09:00 ET
Beyond Air's Annual Meeting: Board Elections and Incentive Plan Expansion
TipRanksMar 14 17:33 ET
Beyond Air's Former CMO Becomes Paid Consultant
TipRanksFeb 16 16:36 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersKalVista Pharma (NASDAQ:KALV) stock moved upwards by 11.0% to $15.99 during Wednesday's after-market session. The market value of their outstanding shares is at $552.5 million. Anitra (AMEX:AZT
BenzingaFeb 14 16:31 ET
G1 Therapeutics, CareCloud Among Healthcare Movers
Seeking AlphaFeb 13 10:00 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersKalVista Pharma (NASDAQ:KALV) stock moved upwards by 31.5% to $21.1 during Tuesday's pre-market session. The market value of their outstanding shares is at $729.1 million. Jin Medical Internati
BenzingaFeb 13 08:06 ET
Earnings Call: Beyond Air Reports Revenue Surge, Eyes FDA Decision
InvestingFeb 13 08:02 ET
Piper Sandler Remains a Buy on Beyond Air (XAIR)
TipRanksFeb 13 07:37 ET
Earnings Call Summary | Beyond Air(XAIR.US) Q3 2024 Earnings Conference
The following is a summary of the Beyond Air, Inc. (XAIR) Q3 2024 Earnings Call Transcript:Financial Performance:Beyond Air reported a significant Q3 revenue increase of over 60% from the previous qua
moomoo AIFeb 13 03:00 ET · Conference Call
Beyond Air Reports Increased Demand for LungFit PH
InvestingFeb 12 18:56 ET
Beyond Air Reiterates FY25 Revenue Guidance Of $12M-$16M Vs $13.82M Est.
"In the third quarter of fiscal year 2024, we reported solid sequential revenue growth of more than 60% compared with the second quarter. This increasing demand for our current LungFit PH system was s
BenzingaFeb 12 16:32 ET
Express News | Beyond Air Q3 EPS $(0.50) Beats $(0.53) Estimate, Sales $391.00K Miss $450.00K Estimate
Moomoo 24/7Feb 12 16:31 ET
12 Health Care Stocks Moving In Monday's After-Market Session
GainersBioSig Technologies (NASDAQ:BSGM) stock increased by 7.7% to $0.96 during Monday's after-market session. The company's market cap stands at $8.9 million. Coeptis Therapeutics (NASDAQ:COEP) shar
BenzingaFeb 12 16:30 ET
No Data
No Data